Edition:
United States

Insider Trading: AbbVie Inc (ABBV.K)

ABBV.K on New York Consolidated

66.09USD
26 May 2017
Change (% chg)

$-0.23 (-0.35%)
Prev Close
$66.32
Open
$66.14
Day's High
$66.41
Day's Low
$66.04
Volume
757,574
Avg. Vol
6,199,225
52-wk High
$68.12
52-wk Low
$55.06

ALBAN CARLOS
Trading Date Type Shares Traded Price Shares Held
3 May 2017 Sell 43,000 $67.00 155,187
27 Feb 2017 Sell 34,721 $62.22 198,187
15 Feb 2017 Buy 29,672 $0.00 232,908
15 Feb 2017 Buy 13,350 $0.00 232,908
9 May 2016 Sell 47,438 $63.52 189,886
28 Feb 2016 Sell 39,930 $56.00 237,324

Institutional Holders

% Shares Owned: 70.31%
# of Holders: 2,124
Total Shares Held: 1,119,019,824
3 Mo. Net Change: 13,838,583
# New Positions: 114
# Closed Positions: 72
# Increased Positions: 806
# Reduced Positions: 869
# Net Buyers: -63

Officers & Directors

Name Age Since Current Position

Richard Gonzalez

63 2013 Chairman of the Board, Chief Executive Officer

William Chase

49 2013 Executive Vice President, Chief Financial Officer

Michael Severino

51 2014 Executive Vice President - Research & Development, Chief Scientific Officer

Laura Schumacher

53 2013 Executive Vice President, External Affairs, General Counsel and Corporate Secretary

Carlos Alban

54 2013 Executive Vice President - Commercial Operations

Henry Gosebruch

44 2015 Executive Vice President, Chief Strategy Officer

Timothy Richmond

50 2013 Senior Vice President - Human Resources

Azita Saleki-Gerhardt

53 2013 Senior Vice President - Operations

Robert Michael

46 2017 Vice President, Controller

Robert Alpern

66 2013 Independent Director

Roxanne Austin

56 2013 Independent Director

William Burnside

65 2013 Independent Director

Brett Hart

47 2016 Independent Director

Edward Liddy

71 2013 Independent Director

Edward Rapp

59 2013 Independent Director

Glenn Tilton

68 2013 Lead Independent Director

Frederick Waddell

63 2013 Independent Director